| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-15 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |